Sign In
Buy ATRA
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications
12:00pm, Monday, 06'th Apr 2020
NEW YORK & CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of safe and effective human-com
Victory Capital Management Inc. Boosts Stock Position in Atara Biotherapeutics Inc (NASDAQ:ATRA)
11:20am, Monday, 06'th Apr 2020
Victory Capital Management Inc. increased its stake in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) by 31.3% in the fourth quarter, according to the company in its most recent 13F filing with the
Canaccord Genuity Thinks Aileron Therapeutics' Stock is Going to Recover
10:12am, Friday, 03'rd Apr 2020
Aileron Therapeutics (ALRN) received a Buy rating and a $5.00 price target from Canaccord Genuity analyst John Newman yesterday. The company's shares
Canaccord Genuity Thinks Aileron Therapeutics’ Stock is Going to Recover
10:12am, Friday, 03'rd Apr 2020
Aileron Therapeutics (ALRN – Research Report) received a Buy rating and a $5.00 price target from Canaccord Genuity analyst John
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Misonix (MSON) and BioNTech SE (BNTX)
10:11am, Friday, 03'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics (ATRA), Misonix (MSON) and BioNTech
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics
